IL-2, Regulatory T Cells, and Tolerance

Journal of Immunology

Volumn 172, Issue 7, 2004, Pages 3983-3988

  Nelson, Brad H ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

AUTOIMMUNITY; CELLULAR IMMUNITY; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOID HYPERPLASIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS;

EID: 1642321982     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.7.3983     Document Type: Short Survey

References (75)

1. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169.
2. Dutcher, J. 2002. Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma. Oncology (Huntingt.) 16:4.
3. Pahwa, S., and M. Morales. 1998. Interleukin-2 therapy in HIV infection. AIDS Patient Care STDS 12:187.
4. Morris, J. C., and T. A. Waldmann. 2000. Advances in interleukin 2 receptor targeted treatment. Ann. Rheum. Dis. 59:i109.
5. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
6. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
7. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
8. + T cells rather than promotion of cell death. Proc. Natl. Acad. Sci. USA 99:3001.
9. Granucci, F., C. Vizzardelli, N. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, and P. Ricciardi-Castagnoli. 2001. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2:882.
10. Yang-Snyder, J. A., and E. V. Rothenberg. 1998. Spontaneous expression of interleukin-2 in vivo in specific tissues of young mice. Dev. Immunol. 5:223.
11. Bassiri, H., and S. R. Carding. 2001. A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection. J. Immunol. 166:5945.
12. Powell, J. D., J. A. Ragheb, S. Kiragawa-Sakakida, and R. H. Schwartz. 1998. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol. Rev. 165:287.
13. Nelson, B. H., and D. M. Willerford. 1998. Biology of the interleukin-2 receptor. Adv. Immunol. 70:1.
14. + T cells. Eur J. Immunol. 25:3053.
15. Ma, A., D. L. Boone, and J. P. Lodolce. 2000. The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J. Exp. Med. 191:753.
16. Contractor, N. V., H. Bassiri, T. Reya, A. Y. Park, D. C. Baumgart, M. A. Wasik, S. G. Emerson, and S. R. Carding. 1998. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2- deficient mice. J. Immunol. 160:385.
17. -/- mice: roles for both IL-2 and IL-15 in CD8αα IEL development. J. Immunol. 163:5906.
18. Suzuki, H., G. S. Duncan, H. Takimoto, and T. W. Mak. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J. Exp. Med. 185:499.
19. Kramer, S., C. Mamalaki, I. Horak, A. Schimpl, D. Kioussis, and T. Hung. 1994. Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur. J. Immunol. 24:2317.
20. Steiger, J., P. W. Nickerson, W. Steurer, M. Moscovitch-Lopatin, and T. B. Strom. 1995. IL-2 knockout recipient mice reject islet cell allografts. J. Immunol. 155:489.
21. Van Parijs, L., A. Biuckians, A. Ibragimov, F. W. Alt, D. M. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:3738.
22. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059.
23. Cousens, L. P., J. S. Orange, and C. B. Biron. 1995. Endogenous IL-2 contributes to T cell expansion and IFN-γ production during lymphocytic choriomeningitis virus infection. J. Immunol. 155:5690.
24. Dai, Z., B. T. Konieczny, F. K. Baddoura, and F. G. Lakkis. 1998. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J. Immunol. 161:1659.
25. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268: 1472.
26. Sharfe, N., H. K. Dadi, M. Shahar, and C. M. Roifman. 1997. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94:3168.
27. Ma, A., M. Datta, E. Margosian, J. Chen, and I. Horak. 1995. T cells, but not B cells, are requited for bowel inflammation in interleukin 2-deficient mice. J. Exp. Med. 182:1567.
28. Leung, D. T., S. Morefield, and D. M. Willerford. 2000. Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo. J. Immunol. 164:3527.
29. + T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol. 25:2618.
30. Kramer, S., A. Schimpl, and T. Hunig. 1995. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp. Med. 182:1769.
31. Ehrhardt, R. O., B. R. Ludviksson, B. Gray, M. Neurath, and W. Strober. 1997. Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 158:566.
32. Carding, S. R., A. C. Hayday, and K. Bottomly. 1991. Cytokines in T-cell development. Immunol. Today 12:239.
33. Wrenshall, L. E., and J. L. Platt. 1999. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J. Immunol. 163:3793.
34. Hanke, T., R. Mirnacht, R. Boyd, and T. Hunig. 1994. Induction of interleukin 2 receptor β chain expression by self-recognition in the thymus. J. Exp. Med. 180:1629.
35. Suzuki, H., A. Hayakawa, D. Bouchard, I. Nakashima, and T. W. Mak. 1997. Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor β chain-deficient mice. Int. Immunol. 9:1367.
36. Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: implications for the nonredundant function of IL-2. Immunity 17:167.
37. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193:70.
38. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
39. Refaeli, Y., L. Van Parijs, C. A. London, J. Tschopp, and A. K. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615.
40. Zheng, C. L. Trageser, D. M. Willerford, and M. J. Lenardo. 1998. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 160:763.
41. Refaeli, Y., L. Van Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196:999.
42. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K. Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11:281.
43. Khoruts, A., A. Mondino, K. A. Pape, S. L. Reiner, and M. K. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187:225.
44. Kneitz, B., T. Herrmann, S. Yonehara, and A. Schimpl. 1995. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J. Immunol. 25:2572.
45. + T cell death. J. Immunol. 163:3131.
46. c chain in primary lymphocyte populations. EMBO J. 17:6551.
47. Malek, T. R., B. O. Porter, E. K. Codias, P. Scibelli, and A. Yu. 2000. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164:2905.
48. D'Souza, W. N., K. S. Schluns, D. Masopust, and L. Lefrancois. 2002. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J. Immunol. 168:5566.
49. + memory T cells by opposing cytokines. Science 288:675.
50. Shrikant, P., and M. F. Mescher. 2002. Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis. J. Immunol. 169:1753.
51. Jonuleit, H., and E. Schmitt. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171:6323.
52. Bach, J. F., and J. Francois Bach. 2003. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3:189.
53. high regulatory cells in human peripheral blood. J. Immunol. 167:1245.
54. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 12:1145.
55. + regulatory T cells through G1TR breaks immunological self-tolerance. Nat. Immunol. 3:135.
56. + T regulatory cells. Nat. Immunol. 4:337.
57. + regulatory T cells. Nat. Immunol. 4:330.
58. Papiernik, M., M. L. de Moraes, C. Pontoux, F. Vasseur, and C. Penit. 1998. Regulatory CD4 T cells: expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:371.
59. + T cell numbers. J. Immunol. 169:4850.
60. Zuniga-Pflucker, J. C., and A. M. Kruisbeek. 1990. Intrathymic radioresistant stem cells follow an IL-2/IL-2R pathway during thymic regeneration after sublethal irradiation. J. Immunol. 144:3736.
61. + suppressor T cells in vivo. Nat. Immunol. 3:33.
62. - subpopulations. J. Immunol. 165:3105.
63. - regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168:5558.
64. Suzuki, H., Y. W. Zhou, M. Kato, T. W. Mak, and I. Nakashima. 1999. Normal regulatory α/β T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor β in vivo. J Exp. Med. 190:1561.
65. - T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 153:3764.
66. + regulatory T cell function. J. Exp. Med. 196:851.
67. Surh, C. D., and J. Sprent. 2002. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands?. J. Exp. Med. 192:F9.
68. + T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31:1637.
69. Snow, J. W., N. Abraham, M. C. Ma, B. G. Herndier, A. W. Pastuszak, and M. A. Goldsmith. 2003. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171:5042.
70. + regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:3435.
71. Blattman, J. N., J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, and R. Ahmed. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9:540.
72. Wrenshall, L. E., J. L. Platt, E. T. Stevens, T. N. Wight, and J. D. Miller. 2003. Propagation and control of T cell responses by heparan sulfate-bound IL-2. J. Immunol. 170:5470.
73. + T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. USA 99:16168.
74. Shimizu, K., R. C. Fields, M. Giedlin, and J. J. Mule. 1999. Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc. Natl. Acad. Sci. USA 96:2268.
75. + T cells. Blood 100:2159.